Decoding the gut-brain axis in depression: mechanistic insights and functional microbiota-based interventions
Journal of Functional Foods · 2025-10 · 133 · 107029
DOI: 10.1016/j.jff.2025.107029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Functional Foods, 2025-10. Verfasst von Panpan Liu und 10 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Depression
Abstract (Originalsprache)
The gut-brain axis has emerged as a critical research focus at the intersection of microbiology, nutrition, and neuropsychiatry, underscoring the complex, bidirectional communication between the gastrointestinal tract and the central nervous system. Accumulating evidence suggests that the gut microbiota plays a pivotal role in the development and potential mitigation of depression through multiple physiological pathways. This review systematically summarizes current advances in understanding how the gut microbiota influences depressive symptoms, with particular attention to mechanisms involving neurotransmitter metabolism, immune system modulation, and hypothalamic-pituitary-adrenal axis regulation. Additionally, the microbial production of neuroactive metabolites and the signaling roles of short-chain fatty acids, indoles, and bile acid derivatives in mood regulation were discussed. The bidirectional nature of gut-brain communication is further explored through the lens of microbial-host interaction, emphasizing how probiotics, prebiotics, and microbial biomarkers modulate gut-brain signaling pathways. Finally, the review outlines emerging strategies and future directions in microbiota-targeted interventions for depression, providing a scientific basis for the development of functional food approaches in mental health management. • The role of gut microbiota in regulating neurotransmitter metabolism, immune response, and HPA axis activity is summarized. • Key microbial taxa and metabolites (e.g., SCFAs, indoles, tryptophan catabolites) associated with depressive phenotypes are identified. • Diagnostic potential of gut microbiota markers in major depressive disorder (MDD) is critically assessed, including multi-omics integration. • Current limitations, ethical considerations, and future research directions for microbiota-based depression interventions are discussed.
Zitieren
APA
Liu, P., Ouyang, Y., Gao, Z., Tan, J., Chen, X., Xiao, Y., Wang, Y., Liu, J., Liu, B., Gao, B., & Zhu, D. (2025). Decoding the gut-brain axis in depression: mechanistic insights and functional microbiota-based interventions. Journal of Functional Foods, 133, 107029. https://doi.org/10.1016/j.jff.2025.107029
Vancouver
Liu P, Ouyang Y, Gao Z, Tan J, Chen X, Xiao Y, et al. Decoding the gut-brain axis in depression: mechanistic insights and functional microbiota-based interventions. Journal of Functional Foods. 2025;133:107029. doi:10.1016/j.jff.2025.107029
BibTeX
@article{Liu2025,
author = {Liu, Panpan and Ouyang, Yerui and Gao, Ziying and Tan, Jiayi and Chen, Xiaodong and Xiao, Yiwen and Wang, Ya and Liu, Jiantao and Liu, Bin and Gao, Boliang and Zhu, Du},
title = {Decoding the gut-brain axis in depression: mechanistic insights and functional microbiota-based interventions},
journal = {Journal of Functional Foods},
year = {2025},
volume = {133},
pages = {107029},
doi = {10.1016/j.jff.2025.107029}
}
EUVIMED